Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsReceivables - NetShares RepurchasedWages, Salaries and Other
Ratios

BridgeBio Pharma (BBIO) Shares Repurchased (2019 - 2025)

BridgeBio Pharma (BBIO) has disclosed Shares Repurchased for 4 consecutive years, with $48.3 million as the latest value for Q1 2025.

  • Quarterly Shares Repurchased changed N/A to $48.3 million in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $48.3 million through Dec 2025, changed N/A year-over-year, with the annual reading at $48.3 million for FY2025, N/A changed from the prior year.
  • Shares Repurchased hit $48.3 million in Q1 2025 for BridgeBio Pharma, up from $1.5 million in the prior quarter.
  • In the past five years, Shares Repurchased ranged from a high of $143.2 million in Q3 2021 to a low of $1.5 million in Q4 2021.